slow or late development of secondary sexual characteristics (e.g. breast) in female

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Searching Images

delayed puberty female secondary sexual characteristics Tanner stages

A clinical photograph shows a 27-year-old female patient with a marked childish appearance, characteristic of severe delayed puberty and primary amenorrhea. The patient exhibits short stature and a youthful facial appearance with pale, slightly puffy skin. Morphological assessment reveals significant underdevelopment of secondary sexual characteristics: the breasts are pre-pubertal (Tanner stage B1-B2), and there is an absence of axillary and pubic hair. The physique is slender with an infantile distribution of subcutaneous fat and a slightly rounded abdomen, inconsistent with chronological adulthood. This visual presentation is indicative of hypogonadotropic hypogonadism, which in this case is associated with a PROP1 gene mutation leading to combined pituitary hormone deficiency (CPHD). The photograph serves as a medical educational example of the physical manifestation of untreated pituitary insufficiency and its impact on skeletal growth and sexual maturation.

A clinical photograph shows a 27-year-old female patient with a marked childish appearance, characteristic of severe delayed puberty and primary amenorrhea. The patient exhibits short stature and a youthful facial appearance with pale, slightly puffy skin. Morphological assessment reveals significant underdevelopment of secondary sexual characteristics: the breasts are pre-pubertal (Tanner stage B1-B2), and there is an absence of axillary and pubic hair. The physique is slender with an infantile distribution of subcutaneous fat and a slightly rounded abdomen, inconsistent with chronological adulthood. This visual presentation is indicative of hypogonadotropic hypogonadism, which in this case is associated with a PROP1 gene mutation leading to combined pituitary hormone deficiency (CPHD). The photograph serves as a medical educational example of the physical manifestation of untreated pituitary insufficiency and its impact on skeletal growth and sexual maturation.

This clinical photograph shows the anterior upper torso of a 21-year-old patient, illustrating a significant lack of secondary sexual characteristics in the breast region. The chest wall appears flat with an absence of glandular breast tissue development (breast hypoplasia or amastia-like appearance). The nipple-areolar complexes are present but small and undeveloped, consistent with a low Tanner stage (B1-B2). The skin over the thorax is unremarkable, with no visible lesions, though the subcutaneous fat layer appears thin. In the context of the provided clinical history, these findings are indicative of delayed puberty or an underlying endocrinological/genetic condition such as primary amenorrhea and Disorders of Sex Development (DSD). The image serves as a clinical reference for evaluating Tanner staging and the physical manifestations of hormonal imbalances or androgen insensitivity syndromes in an adult female-presenting patient.

This clinical photograph shows the anterior upper torso of a 21-year-old patient, illustrating a significant lack of secondary sexual characteristics in the breast region. The chest wall appears flat with an absence of glandular breast tissue development (breast hypoplasia or amastia-like appearance). The nipple-areolar complexes are present but small and undeveloped, consistent with a low Tanner stage (B1-B2). The skin over the thorax is unremarkable, with no visible lesions, though the subcutaneous fat layer appears thin. In the context of the provided clinical history, these findings are indicative of delayed puberty or an underlying endocrinological/genetic condition such as primary amenorrhea and Disorders of Sex Development (DSD). The image serves as a clinical reference for evaluating Tanner staging and the physical manifestations of hormonal imbalances or androgen insensitivity syndromes in an adult female-presenting patient.

A clinical photograph of the anterior chest of a 15-year-old female patient, demonstrating bilateral Tanner stage V breast development. The image shows mature, round, and symmetrical breasts with significant volume and forward projection. The contour is smooth and continuous, indicating full development of the glandular and fatty tissue, consistent with late puberty. The skin appears uniform in texture without visible lesions, striae, or masses. This visual is significant for pediatric and adolescent medicine when assessing pubertal progression and secondary sexual characteristics. In the clinical context of primary amenorrhea, as noted in the metadata, such normal breast development (Tanner stage V) despite a 46,XY karyotype is a characteristic clinical finding in Swyer syndrome (pure gonadal dysgenesis), where the phenotype is typically female despite the chromosomal genotype.

A clinical photograph of the anterior chest of a 15-year-old female patient, demonstrating bilateral Tanner stage V breast development. The image shows mature, round, and symmetrical breasts with significant volume and forward projection. The contour is smooth and continuous, indicating full development of the glandular and fatty tissue, consistent with late puberty. The skin appears uniform in texture without visible lesions, striae, or masses. This visual is significant for pediatric and adolescent medicine when assessing pubertal progression and secondary sexual characteristics. In the clinical context of primary amenorrhea, as noted in the metadata, such normal breast development (Tanner stage V) despite a 46,XY karyotype is a characteristic clinical finding in Swyer syndrome (pure gonadal dysgenesis), where the phenotype is typically female despite the chromosomal genotype.

Clinical photograph of the external genitalia of a patient with dark brown skin tone. The image demonstrates a complete absence of pubic hair (sexual infantility), a key finding in cases of delayed puberty and hormonal deficiencies such as low FSH and LH. The genital morphology shows evidence of Type IV Female Genital Mutilation (FGM), characterized by non-excisive procedures such as pricking or incising. Despite the patient's female social assignment, the visual appearance lacks standard secondary sexual characteristics expected for a 21-year-old, correlating with the provided clinical context of a 46, XY karyotype. The skin in the genital area appears smooth without significant hyperpigmentation or lesions. This image is an educational resource for medical specialties including endocrinology, gynecology, and clinical genetics, illustrating the phenotypic presentation of disorders of sex development (DSD) and the anatomical appearance of specific FGM classifications.

Clinical photograph of the external genitalia of a patient with dark brown skin tone. The image demonstrates a complete absence of pubic hair (sexual infantility), a key finding in cases of delayed puberty and hormonal deficiencies such as low FSH and LH. The genital morphology shows evidence of Type IV Female Genital Mutilation (FGM), characterized by non-excisive procedures such as pricking or incising. Despite the patient's female social assignment, the visual appearance lacks standard secondary sexual characteristics expected for a 21-year-old, correlating with the provided clinical context of a 46, XY karyotype. The skin in the genital area appears smooth without significant hyperpigmentation or lesions. This image is an educational resource for medical specialties including endocrinology, gynecology, and clinical genetics, illustrating the phenotypic presentation of disorders of sex development (DSD) and the anatomical appearance of specific FGM classifications.

Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
I now have everything needed for a comprehensive answer. Let me compile it.

Delayed Development of Secondary Sexual Characteristics in Females

This condition is clinically referred to as delayed puberty or, when absent secondary sexual characteristics accompany absent menses, primary amenorrhea with absent secondary sexual characteristics. It broadly reflects hypogonadism - either from the ovary failing (hypergonadotropic) or the hypothalamic-pituitary axis failing (hypogonadotropic).

Definition & When to Investigate

  • Delayed puberty = absence of secondary sexual characteristics (breast development / thelarche) by age 13 in girls.
  • Normally, breast development is the first sign of estrogen exposure and precedes menarche by ~2 years.
  • Evaluation for primary amenorrhea should be initiated at:
    • Age 15-16 if growth and secondary sexual characteristics are otherwise normal
    • Age 13 if secondary sexual characteristics are absent or height is below the 3rd percentile
    • Within 2 years of breast development if menarche has not occurred
  • Harrison's Principles of Internal Medicine 22E, p. 3174

Clinical Example

The photograph below shows a 27-year-old female with severe delayed puberty (hypogonadotropic hypogonadism due to PROP1 gene mutation): childlike appearance, absent breast development (Tanner B1-B2), and no pubic/axillary hair.
Delayed puberty - absent secondary sexual characteristics (hypogonadotropic hypogonadism)

Classification & Causes

The key initial division is based on gonadotropin levels (FSH/LH):

1. Hypergonadotropic Hypogonadism (High FSH/LH)

  • The ovaries fail to respond → no estrogen feedback → pituitary "shouts" with high gonadotropins.
  • Accounts for 25-40% of delayed puberty in girls.
CauseDetails
Turner Syndrome (45,X)Most common cause. Initially normal ovarian development in utero, then accelerated follicle atresia → streak ovaries. Features: short stature, webbed neck, shield chest, cubitus valgus, low hairline, short 4th metacarpal, multiple pigmented nevi
Gonadal dysgenesis variantsPartial X deletion, mosaicism (45,X/46,XX), pure gonadal dysgenesis (46,XX or 46,XY with streak gonads)
17α-Hydroxylase / 17,20-Lyase deficiency (CYP17 mutation)Primary amenorrhea, no secondary sexual characteristics, female phenotype, hypertension and hypokalemia (excess mineralocorticoid)
Aromatase deficiencyCannot convert androgens → estrogen. At puberty: no breast development, primary amenorrhea, virilization, absent growth spurt, multicystic ovaries. Mother may have been virilized during pregnancy
Congenital lipoid adrenal hyperplasia (StAR mutations)Cannot synthesize any steroid from cholesterol; both 46,XX and 46,XY have female external genitalia; 46,XX patients may develop secondary sexual characteristics partially at puberty
GalactosemiaOvarian failure; usually detected on newborn screening
Autoimmune oophoritis
Chemotherapy / radiation (prepubertal)Alkylating agents (e.g., cyclophosphamide), gonadal irradiation
Gonadotropin receptor mutations (FSHβ, LHR, FSHR mutations)Receptor unresponsive to gonadotropins
  • Berek & Novak's Gynecology, pp. 1858-1865

2. Hypogonadotropic Hypogonadism (Low FSH/LH)

  • Hypothalamic or pituitary failure → inadequate gonadotropin drive to ovaries.
CauseDetails
Constitutional / Physiologic delayMost common hypogonadotropic cause. Delayed reactivation of GnRH pulse generator. Normal physiology, just delayed. Positive family history. Self-resolving
Kallmann SyndromeDeficient pulsatile GnRH secretion + anosmia (patient may not notice). Caused by failure of GnRH neuron migration from olfactory placode during fetal development. X-linked (KAL1/ANOS1), autosomal (FGFR1, PROKR2, others)
CNS tumorsCraniopharyngioma most common; compresses hypothalamus/pituitary, impairs GnRH/gonadotropin release. Almost always associated with other pituitary hormone deficiencies
Functional hypothalamic amenorrhea (HA)Low energy availability from excessive exercise, dieting, or eating disorders (anorexia nervosa). GnRH pulse suppressed. Accounts for ~25% of delayed puberty. Girls are particularly susceptible
Systemic illnessCeliac disease, chronic renal disease, diabetes mellitus, hypothyroidism
ProlactinomaRare in childhood; hyperprolactinemia suppresses GnRH
Congenital hypogonadotropic hypogonadism (CHH)Multiple gene mutations: GNRHR, GNRH1, TAC3, TACR3, KISS1, KISS1R, etc.
5α-Reductase deficiency46,XY with female phenotype and ambiguous genitalia; testes present; virilization at puberty
  • Harrison's Principles of Internal Medicine 22E, p. 3174; Berek & Novak's Gynecology, pp. 1866-1867

Tanner Staging (Breast Development)

Normal breast development progresses through 5 Tanner stages:
StageDescription
B1Prepubertal; elevation of papilla only
B2Breast bud stage; small mound of breast + areola
B3Further enlargement; no separation of contours
B4Areola and papilla project above breast plane
B5Mature breast; papilla projects, areola recessed
In delayed puberty, the girl remains at B1 (prepubertal) beyond age 13.

Initial Evaluation

History: Growth velocity, family history of delayed puberty, exercise habits, eating patterns, anosmia, systemic illness, chemotherapy/radiation, chronic medication use.
Physical exam: Height, weight, Tanner staging, thyroid, signs of Turner syndrome (webbed neck, cubitus valgus, shield chest, low hairline).
Initial screening tests:
  • LH, FSH (high = hypergonadotropic; low/normal = hypogonadotropic)
  • Estradiol
  • Bone age (X-ray of left hand/wrist)
  • TSH, T4 (rule out hypothyroidism)
  • IGF-1, IGFBP-3
  • CBC, ESR/CRP, electrolytes, renal and liver function
  • DHEAS
Secondary tests:
  • Karyotype (if FSH elevated - rule out Turner syndrome and variants)
  • GnRH stimulation test / GnRHa stimulation
  • MRI of brain/pituitary (if hypogonadotropic - rule out craniopharyngioma, etc.)
  • Prolactin
  • Harrison's Principles of Internal Medicine 22E (Table 404-2 & 404-3)

Key Differentiating Points

FeatureHypergonadotropicHypogonadotropic
FSH/LHHighLow or inappropriately normal
OvariesStreak / fibroticSmall but present
KaryotypeMay be abnormal (45,X)Usually 46,XX
AnosmiaAbsentMay be present (Kallmann)
Turner stigmataMay be presentAbsent
MRI pituitaryNormalMay show mass/abnormality
Bone ageNormal or mildly delayedOften delayed

Management Overview

  • Constitutional delay: Watchful waiting; short-course low-dose estrogen may be used to induce puberty if significantly distressing.
  • Hypergonadotropic (gonadal failure): Hormone replacement therapy (HRT) with progressively increasing doses of estrogen, then cyclic estrogen-progesterone to mimic normal puberty and induce/maintain secondary sexual characteristics; protect bone density. If 45,X with Y-cell line mosaicism: gonadectomy (risk of gonadoblastoma).
  • Hypogonadotropic (functional): Treat the underlying cause (nutritional rehabilitation, treatment of systemic illness). Pulsatile GnRH or gonadotropin therapy can induce ovulation for fertility.
  • Kallmann / CHH: Low-dose estrogen for puberty induction; pulsatile GnRH or exogenous gonadotropins for fertility.

Summary Mnemonic

"TRACK" for causes of absent secondary sexual characteristics:
  • Turner syndrome
  • Radiation/chemotherapy (gonadal damage)
  • Aromatase deficiency / Autoimmune oophoritis
  • Constitutional delay / CNS tumors / CHH (Kallmann)
  • Karyotypic gonadal dysgenesis variants
Sources: Harrison's Principles of Internal Medicine 22E (2025), Berek & Novak's Gynecology; Medical Physiology (Boron & Boulpaep)
This is a shared conversation. Sign in to Orris to start your own chat.